{"id":"1267","presentation":"1284 - Evaluation of the Prognostic Factor and the Treatment Efficacy of Inhaled Iloprost in Patients with Group 3 Pulmonary Hypertension","session":"PO-3-PH+CTEPH - Poster Session 3: Pulmonary Hypertension and CTEPH","filename":"ISHLT ePoster.pptx","speaker":"C. Hsu<small>, Tainan, Taiwan<\/small>","photo":"","cover":"https:\/\/s3.us-west-2.amazonaws.com\/us-cslide-prod-presentations\/ishlt2018\/1267\/jpg\/ishlteposter\/thumbnails\/0.png","pdf":"\/file_access\/get_file\/E5947\/session_token\/051d223627253fe4a853c34c506a675b","what":"pdf","code":"","priority":["html5","pdf","jpg","thumbnail"]}
[speaker]
[presentation]
[session]